Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience.
暂无分享,去创建一个
Patrick A. Kupelian | Arul Mahadevan | Twyla R. Willoughby | C. Reddy | E. Klein | P. Kupelian | T. Willoughby | A. Mahadevan | Eric A. Klein | Chandana A. Reddy
[1] C. Reddy,et al. Use of different definitions of biochemical failure after external beam radiotherapy changes conclusions about relative treatment efficacy for localized prostate cancer. , 2006, Urology.
[2] Clifton D Fuller,et al. Comparison of ultrasound and implanted seed marker prostate localization methods: Implications for image-guided radiotherapy. , 2006, International journal of radiation oncology, biology, physics.
[3] Patrick A Kupelian,et al. Influence of intrafraction motion on margins for prostate radiotherapy. , 2006, International journal of radiation oncology, biology, physics.
[4] John T. Wei,et al. Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer. , 2006, International journal of radiation oncology, biology, physics.
[5] David E. Stein,et al. Management of radiotherapy induced rectourethral fistula. , 2006, The Journal of urology.
[6] C. Ma,et al. Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. , 2006, International journal of radiation oncology, biology, physics.
[7] Patrick A Kupelian,et al. Hypofractionated intensity-modulated radiotherapy (70 gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes. , 2005, International journal of radiation oncology, biology, physics.
[8] M. Garzotto,et al. Daily Verification of Prostate Motion Both with and Without a Rectal Balloon (RB) Over the Course of Treatment , 2005 .
[9] W. Tomé,et al. A Multi-Institutional Phase I/II Trial of Dose-per-fraction Escalation for Localized Prostate Cancer , 2005 .
[10] K. Lam,et al. Retrospective analysis of prostate cancer patients with implanted gold markers using off-line and adaptive therapy protocols. , 2005, International journal of radiation oncology, biology, physics.
[11] W. Cavanagh,et al. Rectal fistulas after prostate brachytherapy. , 2005, International journal of radiation oncology, biology, physics.
[12] Patrick A Kupelian,et al. Initial experience with megavoltage (MV) CT guidance for daily prostate alignments. , 2005, International journal of radiation oncology, biology, physics.
[13] Jeff M Michalski,et al. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V. , 2005, International journal of radiation oncology, biology, physics.
[14] Eric Strom,et al. Ultrasound-based localization. , 2005, Seminars in radiation oncology.
[15] L. Schour,et al. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results. , 2005, International journal of radiation oncology, biology, physics.
[16] P. Koper,et al. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. , 2005, International journal of radiation oncology, biology, physics.
[17] Judy Adams,et al. A randomized trial comparing conventional dose (70.2GyE) and high-dose (79.2GyE) conformal radiation in early stage adenocarcinoma of the prostate: Results of an interim analysis of PROG 95–09 , 2004 .
[18] Richard K Valicenti,et al. Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV. , 2004, International journal of radiation oncology, biology, physics.
[19] J. Blasko,et al. Ten-year biochemical relapse-free survival after external beam radiation and brachytherapy for localized prostate cancer: the Seattle experience. , 2003, International journal of radiation oncology, biology, physics.
[20] Frank Van den Heuvel,et al. Independent verification of ultrasound based image-guided radiation treatment, using electronic portal imaging and implanted gold markers. , 2003, Medical physics.
[21] J. Pouliot,et al. Evaluation of ultrasound-based prostate localization for image-guided radiotherapy. , 2003, International journal of radiation oncology, biology, physics.
[22] D. Kuban,et al. Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all? , 2003, International journal of radiation oncology, biology, physics.
[23] F. Vicini,et al. The role of high-dose rate brachytherapy in locally advanced prostate cancer. , 2003, Seminars in radiation oncology.
[24] L. Potters,et al. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. , 2002, International journal of radiation oncology, biology, physics.
[25] David J Brenner,et al. What hypofractionated protocols should be tested for prostate cancer? , 2002, International journal of radiation oncology, biology, physics.
[26] V. Khoo,et al. Hypofractionated conformal radiotherapy in carcinoma of the prostate: five-year outcome analysis. , 2002, International journal of radiation oncology, biology, physics.
[27] R. Bristow,et al. Hypofractionated intensity modulated radiation therapy for prostate cancer , 2002 .
[28] J. Tsai,et al. Implementation and utility of a daily ultrasound-based localization system with intensity-modulated radiotherapy for prostate cancer. , 2002, International journal of radiation oncology, biology, physics.
[29] Michael J. Zelefsky,et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. , 2002, International journal of radiation oncology, biology, physics.
[30] Patrick A Kupelian,et al. Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer. , 2002, International journal of radiation oncology, biology, physics.
[31] E. B. Butler,et al. Prostate immobilization using a rectal balloon , 2002, Journal of applied clinical medical physics.
[32] J. Manola,et al. A practical method to achieve prostate gland immobilization and target verification for daily treatment. , 2001, International journal of radiation oncology, biology, physics.
[33] C. Reddy,et al. Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life. , 2001, International journal of radiation oncology, biology, physics.
[34] C. Reddy,et al. Dose/Volume Relationship of Late Rectal Bleeding After External Beam Radiotherapy for Localized Prostate Cancer: Absolute or Relative Rectal Volume? , 2001, Cancer journal.
[35] J. Rieke,et al. Development of apparatus and phase I trial for stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP) , 2001 .
[36] Blasko,et al. 10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy. , 2001, International journal of radiation oncology, biology, physics.
[37] Rick Chappell,et al. Is α/β for prostate tumors really low? , 2001 .
[38] D Yan,et al. An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process for prostate cancer. , 2000, International journal of radiation oncology, biology, physics.
[39] G. Gustafson,et al. Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial. , 2000, International journal of radiation oncology, biology, physics.
[40] T R Willoughby,et al. Short-course intensity-modulated radiotherapy for localized prostate cancer with daily transabdominal ultrasound localization of the prostate gland. , 2000, International journal of radiation oncology, biology, physics.
[41] Duchesne Gm,et al. What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy. , 1999 .
[42] T E Schultheiss,et al. A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer. , 1999, International journal of radiation oncology, biology, physics.
[43] James D. Cox,et al. Consensus statement: Guidelines for PSA following radiation therapy , 1997 .
[44] E. Klein,et al. Indications for excluding the seminal vesicles when treating clinically localized prostatic adenocarcinoma with radiotherapy alone. , 1997, International Journal of Radiation Oncology, Biology, Physics.
[45] B. Leibovich,et al. Urinary fistulas following external radiation or permanent brachytherapy for the treatment of prostate cancer. , 2005, The Journal of urology.
[46] J Alfred Witjes,et al. The effect of an endorectal balloon and off-line correction on the interfraction systematic and random prostate position variations: a comparative study. , 2005, International journal of radiation oncology, biology, physics.
[47] D. Brenner,et al. Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio), similar to late-responding normal tissue , 2002 .
[48] R. Pötter,et al. The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer. , 2002, International journal of radiation oncology, biology, physics.
[49] A. Renshaw,et al. Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.